Stockreport

Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit

Chemomab Therapeutics Ltd. - American Depositary Shares  (CMMB) 
PDF TEL AVIV, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative [Read more]